Brazil vs Europe (WHO region): New or unknown treatment history cases: Pulmonary, bacteriologically
Brazil
57,187
in 2023
Europe (WHO region)
71,165
in 2023
Brazil rank
12th
Europe (WHO region) rank
11th
New or unknown treatment history cases: Pulmonary, bacteriologically over time
- Brazil
- Europe (WHO region)
How they compare
Europe (WHO region) currently reports 71,165 against 57,187 in Brazil, a difference of 13,978.
That makes Europe (WHO region)'s figure about 1.2 times Brazil's.
Across all 11 years both countries report, Europe (WHO region) has been ahead every year.
Brazil ranks 12th and Europe (WHO region) ranks 11th of 197 countries.
Europe (WHO region) has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Brazil | Europe (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 45,996 | 111,433 | 65,437 | Europe (WHO region) |
| 2020s | 51,314 | 77,212 | 25,899 | Europe (WHO region) |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new or unknown treatment history cases: pulmonary, bacteriologically, Brazil or Europe (WHO region)?
- Europe (WHO region), at 71,165 against 57,187 in Brazil as of 2023.
- What is the difference in new or unknown treatment history cases: pulmonary, bacteriologically between Brazil and Europe (WHO region)?
- 13,978, with Europe (WHO region) ahead.
- How many years of comparable data are there for Brazil and Europe (WHO region)?
- 11 years are reported by both, from 2013 to 2023.
- How do Brazil and Europe (WHO region) rank globally for new or unknown treatment history cases: pulmonary, bacteriologically?
- Brazil ranks 12th and Europe (WHO region) ranks 11th of 197 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New or unknown treatment history cases: Pulmonary, bacteriologically confirmed. Statizoid refreshes it automatically from the source and publishes the full history for both places.